Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Neoplasms 2Neoplasm Metastasis 2Uterine Cervical Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Sarcoma, Kaposi 1Recurrence 1Prostatic Neoplasms 1Melanoma 1Liver Neoplasms 1HIV Infections 1Gastrointestinal Neoplasms 1Esophageal Squamous Cell Carcinoma 1Endometrial Neoplasms 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1Carcinoma 1Breast Neoplasms 1Brain Metastases From Solid Tumors 1Biliary Tract Neoplasms 1Bile Duct Neoplasms 1Advanced Breast Cancer 1Acquired Immunodeficiency Syndrome 1

Interventions

Doxorubicin 5tecogalan 4Liposomes 4Vincristine 3Semaxinib 3Bleomycin 3technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 2Alitretinoin 2vesnarinone 1tin etiopurpurin 1daromun 1Tumor Necrosis Factor-alpha 1Ro 24-7429 1Ritonavir 1Quality of Life 1Patient Reported Outcome Measures 1Paclitaxel 1Nelfinavir 1Molecular Diagnostic Techniques 1Mitoxantrone 1Immunotherapy 1Drug Therapy 1Daunorubicin 1Brentuximab Vedotin 1Biological Therapy 1Bexarotene 14,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone 13-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Sarcoma, Kaposi × Ritonavir × Clear all
NCT00002366 2009-02-20

The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kaposi's Sarcoma

Abbott

Phase 2 Completed
DermatologicSarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, Skin Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡